Catching cancer early is the key to improving survival rates. That's why UT Southwestern's Moncrief Cancer Institute is providing free cancer screenings across Texas to people who are uninsured or underinsured.
UT Southwestern has been ranked the No. 1 hospital in North Texas for the six years in a row, and ranked nationally for 9 specialties areas of health care.
A groundbreaking study showed a 100% response to immunotherapy for a type of rectal cancer. See what the findings mean, who might benefit, and what’s next.
Age 45 is the new milestone for average-risk patients to get their first colorectal cancer screening. Get the latest screening options – including easier colonoscopy prep! – and everything you need to know about getting screened.
As colorectal cancer cases rise in young adults, people in their 30s or 40s must never assume they’re too young to get the disease. Patricio Polanco, M.D., suggests that healthier lifestyle choices and earlier screenings could prevent some of these cases and facilitate early detection. Learn more.
People are fascinated with the human genome at the moment, with the popularity of direct-to-consumer tests such as 23andMe soaring. But Interpreting genetic test results can be complicated, particularly for conditions like colon cancer. At UT Southwestern, our 14 genetic counselor works with patients before and after a comprehensive DNA analysis to determine if they have any hereditary risks.
Health screenings are often the first line of defense against chronic and seasonal illnesses, and physicians incorporate these vital tools to help uncover clues to everything from heart disease and diabetes to colon cancer and coronavirus. Learn about some of the most essential health screenings from one of UT Southwestern's infectious diseases experts.
Stereotactic ablative therapy (SABR) has proven effective in treating many types of primary tumors. Robert Timmerman, M.D., discusses how SABR might improve survival rates for patients with metastatic cancer.
Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.
Is colon cancer screening necessary? A study out of the U.K. published in The BMJ suggests average-risk patients age 50-79 might not need a colonoscopy if they have low risk-score. But Syed Kazmi, M.D., disagrees when it comes to U.S. patients. Find out why in this MedBlog.
By 2030, researchers expect up to a 90 percent increase in colon cancer diagnoses in millennials. But why? In this MedBlog, Syed Kazmi, M.D., discusses whether the U.S. food staple high-fructose corn syrup is to blame and offers tips for millennials to reduce their risk. Learn more.
An important part of life after cancer is balancing good health and enjoying life to the fullest. Discover how tumor surveillance can help improve the physical and mental well-being of patients who survive cancer recurrence.
